Covalent small-molecule RNA targeting in Alzheimer's disease: computational strategies, challenges and opportunities
{{output}}
RNA dysfunction is increasingly recognized as an upstream driver of Alzheimer's disease pathology, and covalent small molecules that engage pathogenic RNA structures are emerging as a therapeutic strategy. In addition to its role as a template, RNA governs am... ...
